Welcome to CDC Stacks | Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses? - 4215 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?
  • Published Date:
    Jun 30 2009
  • Source:
    PLoS Med. 6(6).
Filetype[PDF - 72.35 KB]


No Related Documents.
You May Also Like:
  1. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of Oseltamivir resistance among circulating influenza A (H1N1 ) viruses, 2008-09 influenza season
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    12/19/08
    Source:
    HAN ; 279
    Series:
    HAN ; 279
    Description:
    Friday, December 19, 2008, 11:50 EST (11:50 AM EST) : CDCHAN-00279-2008-12-19-ADV-N : Although influenza activity is low in the United States to date, preliminary data from a limited number of states indicate that the prevalence of influenza A (H1N1)...
    File Type:
    Filetype[PDF - 47.86 KB]
  2. Antiviral Response in Pandemic Influenza Viruses
    Personal Author:
    García-Sastre, Adolfo
    Published:
    Jan 2006
    Source:
    Emerg Infect Dis. 12(1):44-47.
    Description:
    The outcome of viral infections depends on a complex set of interactions between the viruses and their hosts. Particularly, viral infection triggers specific signaling programs within the infected cells that results in substantial changes in host gen...
    File Type:
    Filetype[PDF - 35.95 KB]
  3. Optimizing Distribution of Pandemic Influenza Antiviral Drugs
    Personal Author:
    Singh, Bismark; Huang, Hsin-Chan; Morton, David P.; Johnson, Gregory P.; Gutfraind, Alexander; Galvani, Alison P.; Clements, Bruce; Meyers, Lauren A.;
    Published:
    Feb 2015
    Source:
    Emerg Infect Dis. 21(2):251-258.
    Description:
    We provide a data-driven method for optimizing pharmacy-based distribution of antiviral drugs during an influenza pandemic in terms of overall access for a target population and apply it to the state of Texas, USA. We found that during the 2009 influ...
    File Type:
    Filetype[PDF - 725.90 KB]
  4. Can we change the risk of autism?
    Personal Author:
    Berry, Robert J; Crider, Krista Stimson; Yeargin-Allsopp, Marshalyn;
    Published:
    Feb 13 2013
    Source:
    JAMA. 309(6):611-613.
    File Type:
    Filetype[PDF - 49.05 KB]
  5. Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California
    Personal Author:
    Hunter, Jennifer C; Rodríguez, Daniela C; Aragón, Tomás J;
    Published:
    Jan 25 2012
    Source:
    BMC Public Health. 2012; 12:82.
    Description:
    Background : The large-scale deployment of antiviral drugs from the Strategic National Stockpile during the 2009 H1N1 influenza response provides a unique opportunity to study local public health implementation of the medical countermeasure dispensin...
    File Type:
    Filetype[PDF - 285.87 KB]